Clinical trials help researchers learn more about potential treatment options for Alzheimer’s disease and other medical conditions. Having a broad range of study participants with diverse ethnicities, genders, ages, and socio-economic backgrounds is important because it allows researchers to gather information on how a potential treatment may affect different people. This video from the National Institute on Aging (NIA) explains more.